Stock Research: Santen Pharmaceutical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Santen Pharmaceutical

TYO:4536 JP3336000009
30
  • Value
    51
  • Growth
    59
  • Safety
    Safety
    56
  • Combined
    59
  • Sentiment
    32
  • 360° View
    360° View
    30
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company focused on the research, development, manufacturing, and sales of pharmaceutical products. It operates in medical pharmaceutical, OTC drugs, medical devices, and other businesses, including the cleaning business. The company operates in Japan, Europe, Asia, and North America markets. In the last fiscal year, the company had 3849 employees, a market cap of $3814 million, profits of $1141 million, and revenue of $2001 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 72 70 77
Growth
59 20 51 43
Safety
Safety
56 61 80 84
Sentiment
32 58 70 27
360° View
360° View
30 55 94 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
41 65 39 31
Opinions Change
15 59 82 50
Pro Holdings
n/a 40 100 37
Market Pulse
69 56 26 47
Sentiment
32 58 70 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 72 70 77
Growth
59 20 51 43
Safety Safety
56 61 80 84
Combined
59 50 90 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
48 63 62 59
Price vs. Earnings (P/E)
67 76 63 78
Price vs. Book (P/B)
35 45 56 67
Dividend Yield
70 72 76 88
Value
51 72 70 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
20 4 8 16
Profit Growth
33 58 94 96
Capital Growth
85 23 23 43
Stock Returns
61 46 79 37
Growth
59 20 51 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
63 54 63 74
Refinancing
45 44 63 61
Liquidity
76 64 76 84
Safety Safety
56 61 80 84

Similar Stocks

Discover high‑ranked alternatives to Santen Pharmaceutical and broaden your portfolio horizons.

Mitsubishi HC Capital

TYO:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

Systena

TYO:2317
Country: Japan
Industry: Application Software
Size: Medium
Full Stock Analysis

Prestige International

TYO:4290
Country: Japan
Industry: Diversified Support Services
Size: Medium
Full Stock Analysis

Fuji

TYO:6134
Country: Japan
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: